Published in Soft Matter on October 21, 2010
Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials. Exp Neurol (2013) 0.96
Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol (2012) 0.95
Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation. Exp Neurol (2012) 0.90
Combination therapies in the CNS: engineering the environment. Neurosci Lett (2012) 0.88
Repair of injured spinal cord using biomaterial scaffolds and stem cells. Stem Cell Res Ther (2014) 0.87
Regenerative medicine for the treatment of spinal cord injury: more than just promises? J Cell Mol Med (2012) 0.87
Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia. Biomaterials (2012) 0.85
Collagen microsphere serving as a cell carrier supports oligodendrocyte progenitor cell growth and differentiation for neurite myelination in vitro. Stem Cell Res Ther (2013) 0.84
Regenerative therapies for central nervous system diseases: a biomaterials approach. Neuropsychopharmacology (2013) 0.84
Extracellular matrices, artificial neural scaffolds and the promise of neural regeneration. Neural Regen Res (2014) 0.84
Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury. J Control Release (2015) 0.81
Survival, Differentiation, and Migration of High-Purity Mouse Embryonic Stem Cell-derived Progenitor Motor Neurons in Fibrin Scaffolds after Sub-Acute Spinal Cord Injury. Biomater Sci (2014) 0.80
Combination therapy of stem cell derived neural progenitors and drug delivery of anti-inhibitory molecules for spinal cord injury. Acta Biomater (2015) 0.79
The effects of controlled release of neurotrophin-3 from PCLA scaffolds on the survival and neuronal differentiation of transplanted neural stem cells in a rat spinal cord injury model. PLoS One (2014) 0.79
Combining adult stem cells and olfactory ensheathing cells: the secretome effect. Stem Cells Dev (2013) 0.78
Tissue engineered constructs for peripheral nerve surgery. Eur Surg (2013) 0.78
Stem cells for spinal cord injury: Strategies to inform differentiation and transplantation. Biotechnol Bioeng (2016) 0.77
Combination scaffolds of salmon fibrin, hyaluronic acid, and laminin for human neural stem cell and vascular tissue engineering. Acta Biomater (2016) 0.77
Sculpting the blank slate: how fibrin's support of vascularization can inspire biomaterial design. Acta Biomater (2013) 0.77
Rodent Models and Behavioral Outcomes of Cervical Spinal Cord Injury. J Spine (2013) 0.76
A puromycin selectable cell line for the enrichment of mouse embryonic stem cell-derived V3 interneurons. Stem Cell Res Ther (2015) 0.76
Generation and applications of human pluripotent stem cells induced into neural lineages and neural tissues. Front Physiol (2012) 0.76
The Potential for iPS-Derived Stem Cells as a Therapeutic Strategy for Spinal Cord Injury: Opportunities and Challenges. J Clin Med (2014) 0.76
Covalent growth factor tethering to direct neural stem cell differentiation and self-organization. Acta Biomater (2017) 0.75
Neurotransplantation: lux et veritas, fiction or reality? J Neurosurg Sci (2011) 0.75
Dynamic behaviors of astrocytes in chemically modified fibrin and collagen hydrogels. Integr Biol (Camb) (2016) 0.75
Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment. Sci Rep (2017) 0.75
Stem cell therapy for white matter disorders: don't forget the microenvironment! J Inherit Metab Dis (2016) 0.75
In vitro selection technologies to enhance biomaterial functionality. Exp Biol Med (Maywood) (2016) 0.75
Endometriotic Epithelial Cell Response to Macrophage-Secreted Factors is Dependent on Extracellular Matrix Context. Cell Mol Bioeng (2014) 0.75
Neurogenesis in the adult human hippocampus. Nat Med (1998) 17.53
A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma (1995) 13.48
Embryonic stem cells express neuronal properties in vitro. Dev Biol (1995) 5.03
Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med (1999) 4.44
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J (2007) 4.32
Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release (2000) 2.33
Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci (2006) 2.13
Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol (2001) 2.12
Efficient testing of motor function in spinal cord injured rats. Brain Res (2000) 1.61
Differentiation of engrafted neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp Neurol (2002) 1.53
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release (2004) 1.32
Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials (2006) 1.29
Neurotrophin-induced differentiation of human embryonic stem cells on three-dimensional polymeric scaffolds. Tissue Eng (2005) 1.25
The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds. Stem Cells (2007) 1.23
Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release (2006) 1.19
Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J Neurosci (2001) 1.10
Characterization and intraspinal grafting of EGF/bFGF-dependent neurospheres derived from embryonic rat spinal cord. Brain Res (2000) 1.08
The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res (2008) 1.06
Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. J Biomed Mater Res A (2010) 1.06
Embryonic precursor cells that express Trk receptors: induction of different cell fates by NGF, BDNF, NT-3, and CNTF. Exp Neurol (1997) 1.04
Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release (2006) 1.04
Autocrine/paracrine platelet-derived growth factor regulates proliferation of neural progenitor cells. Cancer Res (2006) 1.03
Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009) 1.01
Transplantation of embryonic spinal cord-derived neurospheres support growth of supraspinal projections and functional recovery after spinal cord injury in the neonatal rat. J Neurosci Res (2005) 0.95
Repeated injuries dramatically affect cells of the oligodendrocyte lineage: effects of PDGF and NT-3 in vitro. Glia (2005) 0.87
Bioengineering neural stem/progenitor cell-coated tubes for spinal cord injury repair. Cell Transplant (2008) 0.87
Cyclosporin-A enhances non-functional axonal growing after complete spinal cord transection. Brain Res (2007) 0.83
Effect of cyclosporin A on functional recovery in the spinal cord following contusion injury. J Anat (2009) 0.82
Acute, subacute and chronic effect of cyclosporin-A on mean arterial pressure of rats with severe spinal cord contusion. Neurosci Lett (2008) 0.78
The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials (2008) 1.58
Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp Neurol (2003) 1.49
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J Control Release (2004) 1.32
Approaches to neural tissue engineering using scaffolds for drug delivery. Adv Drug Deliv Rev (2007) 1.28
Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties. ACS Nano (2009) 1.28
The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds. Stem Cells (2007) 1.23
The early effects of sustained platelet-derived growth factor administration on the functional and structural properties of repaired intrasynovial flexor tendons: an in vivo biomechanic study at 3 weeks in canines. J Hand Surg Am (2007) 1.22
Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J Control Release (2006) 1.19
Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. J Biomed Mater Res A (2007) 1.15
Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration. Acta Biomater (2008) 1.08
The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res (2008) 1.06
Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury. J Biomed Mater Res A (2010) 1.06
Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplant (2009) 1.04
Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J Control Release (2006) 1.04
Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury. Biotechnol Bioeng (2009) 1.01
Anisotropic mechanical properties of magnetically aligned fibrin gels measured by magnetic resonance elastography. J Biomech (2009) 1.00
BMP12 induces tenogenic differentiation of adipose-derived stromal cells. PLoS One (2013) 1.00
Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev (2007) 0.99
Differential gene expression in motor and sensory Schwann cells in the rat femoral nerve. J Neurosci Res (2011) 0.95
Development of rationally designed affinity-based drug delivery systems. Acta Biomater (2005) 0.94
Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system. J Biomed Mater Res A (2009) 0.93
The effect of endosomal escape peptides on in vitro gene delivery of polyethylene glycol-based vehicles. J Gene Med (2008) 0.93
Fibrin matrices with affinity-based delivery systems and neurotrophic factors promote functional nerve regeneration. Biotechnol Bioeng (2010) 0.93
Conductive Core-Sheath Nanofibers and Their Potential Application in Neural Tissue Engineering. Adv Funct Mater (2009) 0.92
The early inflammatory response after flexor tendon healing: a gene expression and histological analysis. J Orthop Res (2014) 0.92
Schwann cells seeded in acellular nerve grafts improve functional recovery. Muscle Nerve (2013) 0.89
Direct reprogramming of mouse fibroblasts to cardiomyocyte-like cells using Yamanaka factors on engineered poly(ethylene glycol) (PEG) hydrogels. Biomaterials (2013) 0.89
Combination therapies in the CNS: engineering the environment. Neurosci Lett (2012) 0.88
A systematic evaluation of Schwann cell injection into acellular cold-preserved nerve grafts. J Neurosci Methods (2011) 0.88
Transgenic enrichment of mouse embryonic stem cell-derived progenitor motor neurons. Stem Cell Res (2011) 0.86
Generation of v2a interneurons from mouse embryonic stem cells. Stem Cells Dev (2014) 0.85
Release rate controls biological activity of nerve growth factor released from fibrin matrices containing affinity-based delivery systems. J Biomed Mater Res A (2008) 0.85
Engineering peripheral nerve repair. Curr Opin Biotechnol (2013) 0.84
Heparin-binding-affinity-based delivery systems releasing nerve growth factor enhance sciatic nerve regeneration. J Biomater Sci Polym Ed (2010) 0.82
Controlled delivery of glial cell line-derived neurotrophic factor enhances motor nerve regeneration. J Hand Surg Am (2010) 0.81
A microdevice platform for visualizing mitochondrial transport in aligned dopaminergic axons. J Neurosci Methods (2012) 0.81
Synthesis and characterization of four-arm poly(ethylene glycol)-based gene delivery vehicles coupled to integrin and DNA-binding peptides. Mol Pharm (2007) 0.80
A new method for generating high purity motoneurons from mouse embryonic stem cells. Biotechnol Bioeng (2014) 0.80
Development of novel poly(ethylene glycol)-based vehicles for gene delivery. Biotechnol Bioeng (2007) 0.79
Viral transduction of primary Schwann cells using a Cre-lox system to regulate GDNF expression. Biotechnol Bioeng (2014) 0.77
Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides. Acta Biomater (2008) 0.77
Kinetic analysis of neurotrophin-3-mediated differentiation of embryonic stem cells into neurons. Tissue Eng Part A (2009) 0.76
Analysis of cell binding and internalization of multivalent PEG-based gene delivery vehicles. IEEE Trans Nanobioscience (2011) 0.76
Abstract 91: Engineering Primary Schwann Cells using Lentiviruses to Control GDNF Expression. Plast Reconstr Surg (2014) 0.75
Getting your research out there: open access & more. Ann Biomed Eng (2012) 0.75
Effects of borate-based bioactive glass on neuron viability and neurite extension. J Biomed Mater Res A (2013) 0.75